SMG vs. JAZZ
Compare and contrast key facts about The Scotts Miracle-Gro Company (SMG) and Jazz Pharmaceuticals plc (JAZZ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SMG or JAZZ.
Correlation
The correlation between SMG and JAZZ is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SMG vs. JAZZ - Performance Comparison
Loading data...
Key characteristics
SMG:
-0.30
JAZZ:
-0.14
SMG:
-0.03
JAZZ:
0.13
SMG:
1.00
JAZZ:
1.02
SMG:
-0.14
JAZZ:
-0.06
SMG:
-0.47
JAZZ:
-0.27
SMG:
23.02%
JAZZ:
10.13%
SMG:
45.66%
JAZZ:
34.43%
SMG:
-83.55%
JAZZ:
-96.90%
SMG:
-73.26%
JAZZ:
-44.78%
Fundamentals
SMG:
$3.40B
JAZZ:
$6.34B
SMG:
$0.58
JAZZ:
$7.36
SMG:
101.72
JAZZ:
13.98
SMG:
0.27
JAZZ:
3.78
SMG:
0.98
JAZZ:
1.56
SMG:
18.98
JAZZ:
1.52
SMG:
$3.45B
JAZZ:
$4.06B
SMG:
$961.70M
JAZZ:
$3.45B
SMG:
$279.70M
JAZZ:
$1.28B
Returns By Period
In the year-to-date period, SMG achieves a -10.27% return, which is significantly higher than JAZZ's -13.45% return. Over the past 10 years, SMG has outperformed JAZZ with an annualized return of 1.84%, while JAZZ has yielded a comparatively lower -5.01% annualized return.
SMG
-10.27%
14.26%
-17.56%
-13.55%
-13.31%
1.84%
JAZZ
-13.45%
4.76%
-16.50%
-4.84%
-0.84%
-5.01%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SMG vs. JAZZ — Risk-Adjusted Performance Rank
SMG
JAZZ
SMG vs. JAZZ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for The Scotts Miracle-Gro Company (SMG) and Jazz Pharmaceuticals plc (JAZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
SMG vs. JAZZ - Dividend Comparison
SMG's dividend yield for the trailing twelve months is around 4.48%, while JAZZ has not paid dividends to shareholders.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SMG The Scotts Miracle-Gro Company | 4.48% | 3.98% | 4.14% | 5.43% | 1.59% | 1.21% | 2.13% | 3.51% | 1.93% | 2.03% | 2.85% | 6.06% |
JAZZ Jazz Pharmaceuticals plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
SMG vs. JAZZ - Drawdown Comparison
The maximum SMG drawdown since its inception was -83.55%, smaller than the maximum JAZZ drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for SMG and JAZZ. For additional features, visit the drawdowns tool.
Loading data...
Volatility
SMG vs. JAZZ - Volatility Comparison
The current volatility for The Scotts Miracle-Gro Company (SMG) is 13.90%, while Jazz Pharmaceuticals plc (JAZZ) has a volatility of 15.88%. This indicates that SMG experiences smaller price fluctuations and is considered to be less risky than JAZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
SMG vs. JAZZ - Financials Comparison
This section allows you to compare key financial metrics between The Scotts Miracle-Gro Company and Jazz Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SMG vs. JAZZ - Profitability Comparison
SMG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Scotts Miracle-Gro Company reported a gross profit of 547.90M and revenue of 1.42B. Therefore, the gross margin over that period was 38.6%.
JAZZ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported a gross profit of 793.22M and revenue of 897.84M. Therefore, the gross margin over that period was 88.4%.
SMG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Scotts Miracle-Gro Company reported an operating income of 344.70M and revenue of 1.42B, resulting in an operating margin of 24.3%.
JAZZ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported an operating income of -55.89M and revenue of 897.84M, resulting in an operating margin of -6.2%.
SMG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Scotts Miracle-Gro Company reported a net income of 217.50M and revenue of 1.42B, resulting in a net margin of 15.3%.
JAZZ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported a net income of -92.54M and revenue of 897.84M, resulting in a net margin of -10.3%.